Health-related Quality of Life Analysis from ENTER, a Randomized, Controlled Phase III Trial of Whole-Brain Radiotherapy with and Without Concurrent Erlotinib in NSCLC with Brain Metastases.
TRANSLATIONAL LUNG CANCER RESEARCH（2024）
关键词
Non-small cell lung cancer (NSCLC),brain metastases (BM),whole-brain radiotherapy (WBRT),health-related quality of life (HRQoL),erlotinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要